Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 12 - Sep 17
29 , e8 (2019)
But both medications have shown remarkable results in promoting weight loss for individuals with or without diabetes, providing a revolutionary solution for those struggling to lose weight
Across the SURPASS-1 to -5 clinical studies, tirzepatide 5, 10 and 15 mg demonstrated significant improvements in glycated haemoglobin A1c (HbA1c) ( 1.9 to 2.6%), body weight ( 6.6 to 13.9%) and systolic blood pressure (SBP) ( 2.8 to 12.6 mmHg) at the end of study treatment
Drawing 60 units from a 5 mg/mL vial would deliver 3.0 mg, which exceeds standard protocols
The company is now focusing on other investigational treatments, including a new oral candidate targeting the GIPR pathway, which is currently undergoing phase two clinical trials
Hair Growth
